The EUROHEP.NET project addressed issues related to surveillance and prevention of hepatitis A and B in the EU countries, Associated States and Israel (28 countries) with a view to study the feasibility of a future network on surveillance and prevention and to speed up the progress of these countries towards control of hepatitis A and B.
EUROHEP.NET targetted 28 countries including the 15 countries of the European Union (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden and UK), the 12 Associated States (Bulgaria, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia) and Israel.
The overall aim of this concerted action was to take stock, co-ordinate, strengthen and standardise the country-specific surveillance and prevention activity of viral hepatitis A and B. This has be achieved by establishing a feasibility study of a future network on surveillance of hepatitis A and B in the 28 participating countries, integrating the expert epidemiology and public health groups involved in the surveillance of infectious diseases in the respective countries.